Literature DB >> 23477401

Call for fellowship programs in stem cell-based regenerative and cellular medicine: new stem cell training is essential for physicians.

Paul S Knoepfler1.   

Abstract

Stem cell-based regenerative and cellular medicine is an exciting, emerging area of medical practice. While bone marrow transplantation, a stem cell-based therapy, has been a part of medicine for decades, in recent years newer and more diverse forms of stem cell-based therapies are being used to treat a rapidly growing population of patients in the USA as well as worldwide. Nonetheless, to this author's knowledge, there is currently not a single academic medical fellowship training program in the USA that specifically prepares physicians for treating patients with stem cell-based therapies other than bone marrow or hematopoietic stem cell transplantation. An increasing number of physicians untrained in stem cell-based regenerative and cellular medicine are nonetheless transplanting stem cells into hundreds if not thousands of patients for a striking diversity of conditions. Furthermore, as stem cell technology advances, a growing number of physicians with academic affiliations may look to legitimately practice regenerative and cellular medicine. What little training that physicians can currently obtain must be found on an ad hoc basis. This article should act as a call for the development of formal academic medical fellowship programs to train physicians in the practice of cellular and regenerative medicine. The USA is used here as an example of a medical sphere in which it can be argued that such training would be helpful, however such programs would be quite helpful globally.

Entities:  

Mesh:

Year:  2013        PMID: 23477401      PMCID: PMC3698965          DOI: 10.2217/rme.13.1

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  5 in total

1.  Stem cells. Texas Medical Board approves rules for controversial treatment.

Authors:  Jocelyn Kaiser
Journal:  Science       Date:  2012-04-20       Impact factor: 47.728

2.  FDA challenges stem-cell clinic.

Authors:  David Cyranoski
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

3.  Texas legitimizes path around FDA oversight.

Authors:  Laura DeFrancesco
Journal:  Nat Biotechnol       Date:  2012-05-07       Impact factor: 54.908

4.  Perspective: communications with the Food and Drug Administration on the development pathway for a cell-based therapy: why, what, when, and how?

Authors:  Ellen G Feigal; Katherine Tsokas; Jiwen Zhang; Marc V Cromer; Kevin J Whittlesey; Michael J Werner
Journal:  Stem Cells Transl Med       Date:  2012-10-17       Impact factor: 6.940

5.  FDA's claims over stem cells upheld.

Authors:  David Cyranoski
Journal:  Nature       Date:  2012-08-02       Impact factor: 49.962

  5 in total
  7 in total

1.  Key action items for the stem cell field: looking ahead to 2014.

Authors:  Paul S Knoepfler
Journal:  Stem Cells Dev       Date:  2013-10-22       Impact factor: 3.272

2.  Clinical research skills development program in cell-based regenerative medicine.

Authors:  Ivonne Hernandez Schulman; Viky Suncion; Vasileios Karantalis; Wayne Balkan; Joshua M Hare
Journal:  Stem Cells Transl Med       Date:  2014-12-29       Impact factor: 6.940

3.  A training program in cardiovascular cell-based therapy: from the NHLBI Cardiovascular Cell Therapy Research Network.

Authors:  John W Petersen; David E Winchester; Ki Park; Anita D Szady; Domenico G Della Rocca; Mustafa Ahmed; Hillary Tassin; Yanfei Qi; Carl J Pepine
Journal:  Regen Med       Date:  2014       Impact factor: 3.806

Review 4.  How to establish infrastructures to achieve more efficient regenerative medicine?

Authors:  Babak Arjmand; Bagher Larijani; Sepideh Alavi-Moghadam; Hamid Reza Aghayan; Mostafa Rezaei-Tavirani; Parisa Goodarzi; Akram Tayanloo-Beik; Mahmood Biglar; Mohsen Rajaeinejad; Fatemeh Fazeli Shouroki
Journal:  Cell Tissue Bank       Date:  2022-07-24       Impact factor: 1.752

Review 5.  From bench to FDA to bedside: US regulatory trends for new stem cell therapies.

Authors:  Paul S Knoepfler
Journal:  Adv Drug Deliv Rev       Date:  2014-12-07       Impact factor: 15.470

6.  Regenology: Time for a New Specialty?

Authors:  Shawn Johnson; Anthony Atala
Journal:  Stem Cells Transl Med       Date:  2018-11-09       Impact factor: 6.940

7.  Effectiveness of interactive teaching intervention on medical students' knowledge and attitudes toward stem cells, their therapeutic uses, and potential research applications.

Authors:  Fayez Abdulrazeq; Khalid A Kheirallah; Abdel-Hameed Al-Mistarehi; Samir Al Bashir; Mohammad A ALQudah; Abdallah Alzoubi; Jomana Alsulaiman; Mazhar S Al Zoubi; Abdulwahab Al-Maamari
Journal:  PeerJ       Date:  2022-01-21       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.